05/04/2022
Pharmaceutical companies can help patients learn to use digital tools through surveys and interviews at the study design stage. They can also orient sites during feasibility, selection and startup towards the integration of patient-facing tools.
Read more about what patients expect from decentralization, and how to address their biggest challenges, here: https://dt-consulting.com/dts-clinical-trial-digital-tracker-q1-2022/
April 5, 2022 DT’s Clinical Trial Digital Tracker, Q1 2022 by Francesca Properzi with Carlos Capella and Tim van Tongeren Executive Summary DT’s third Clinical Trial Digital Tracker assesses the state of digital technology adoption by clinical trial sites globally. Our first two trackers in 2021...